Processa Pharma Enters Research Collaboration With Generian Pharma
Processa Pharma entered a research collaboration with Generian Pharma on a novel oral macrocyclic peptide-based neonatal Fc receptor antagonist program.
Related stories
World Kinect Reports Quarterly Results for Period Ended September 30
M impact | EQUITY | Oct 29, 2026, 11:15 PM UTC
Strattec Security Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Oct 29, 2026, 11:14 PM UTC
Mohawk Industries Reports Quarterly Results for Quarter Ended September 30
A machine-generated LSEG summary reports Mohawk Industries' results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:14 PM UTC
TMX Group Q3 Revenue Beats Estimates on Double-Digit TMX VettaFi Growth
M impact | EQUITY | Oct 29, 2026, 11:14 PM UTC
Capstone Copper Reports Quarterly Results for Quarter Ended September 30
M impact | EQUITY | Oct 29, 2026, 11:14 PM UTC
Alphabet Drops as Wall Street Closes Lower
Wall Street closed lower as Alphabet, Google's parent company, fell.
L impact | EQUITY | Oct 29, 2026, 11:14 PM UTC